TNF and uveitis: Adalimumab is a widely used biologic anti-TNF-α-agent for moderate to severe hidradenitis suppurativa and many other autoimmune diseases, including rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, and uveitis of the posterior segment.